Gilead Sciences (GILD) Market Capitalization (2009 - 2026)

Gilead Sciences (GILD) has reported Market Capitalization for 18 consecutive years, with $156.8 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 13.86% year-over-year to $156.8 billion; the trailing twelve-month figure through Jun 2026 stood at $156.8 billion (up 13.86% YoY), and the FY2025 full-year result was $152.3 billion, up 32.35% from the prior year.
• Market Capitalization retreated to $156.8 billion in Q2 2026 per GILD's latest filing, from $173.1 billion in the prior quarter.
• Across five years, Market Capitalization topped out at $173.1 billion in Q1 2026 and bottomed at $74.6 billion in Q1 2022.
• Historically, Market Capitalization has averaged $112.5 billion across 5 years, with a median of $104.0 billion in 2023.
• The sharpest annual moves came in 2024 and 2025: Market Capitalization retreated 11.86% in 2024, then jumped 61.08% in 2025.
• Over 5 years, Market Capitalization stood at $107.1 billion in 2022, then slipped by 5.71% to $100.9 billion in 2023, then rose by 14.02% to $115.1 billion in 2024, then soared by 32.35% to $152.3 billion in 2025, then advanced by 2.93% to $156.8 billion in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $156.8 billion, $173.1 billion, and $152.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.